Skip to content
10-K

Annual Report

BioNeutral Group, Inc

0001213900-13-000399

← back to feed
Filed
Jan 29, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Jan 24, 2013 126.73M sh
Operating Cash Flow FY 2012 · Oct 31, 2011 −$881.18K
Stockholders Equity FY 2012 · Oct 31, 2011 $5.38M
Current Liabilities FY 2012 · Oct 31, 2011 $2.94M
Total Liabilities FY 2012 · Oct 31, 2011 $5.01M
Current Assets FY 2012 · Oct 31, 2011 $13.41K
Total Assets FY 2012 · Oct 31, 2011 $10.72M
Rd Expense FY 2012 · Oct 31, 2011 $630.77K
Net Income FY 2012 · Oct 31, 2011 −$2.82M
Operating Income FY 2012 · Oct 31, 2011 −$2.9M
Gross Profit FY 2012 · Oct 31, 2011 $32.95K
Cost Of Revenue FY 2012 · Oct 31, 2011 $20.63K
Revenue FY 2012 · Oct 31, 2011 $53.58K